What is on the Horizon? A Symposium on the future of ophthalmology at Euretina 2021
Home monitoring, intravitreal treatments, gene therapy, AI. The future of ophthalmology through the eyes of international thought leaders.
LEARN MOREEuretina 2021 Virtual Congress
The 21st EURETINA meeting, which took place virtually for the second year due to the pandemic, hosted a lot of events, lectures, symposia, and instructional courses in order to keep retina specialists always up-to-date.
New insight on PCV and pachychoroid
Prof. Gemmy Cheung, MD, FRCOphth, Associate Professor and Senior Consultant at the Singapore National Eye Center, summarises her lecture about the new insights on PCV and pachychoroid.
Efficacy and safety of intravitreal aflibercept treat-and-extend compared with fixed dosing for neovascular age-related macular degeneration: The AZURE study
Prof. Laurent Kodjikian, MD, PhD, Professor of Ophthalmology and Chair of the University of Lyon, France and Associate Chair of the Department of Ophthalmology at Croix-Rousse University Hospital in Lyon, France discusses the latest updates of the AZURE study.
Lessons learned from the first trial on ILM peeling with and without robotics
Prof. Marc de Smet, MD, PhD, Professor and Head of MIOS sa, CMO of Preceyes, speaks about his lecture about ILM peeling with and without robotics.
Fluid in nAMD: a pragmatic approach
Nancy Holekamp, MD, Director of Retina Services at the Pepose Vision Institute in St. Louis, USA, resumes her presentation at this year’s EURETINA about fluid management in AMD.
Novel VR surgery for complex diabetic TRD
Prof. Sundaram Natarajan, MD, Chairman and Managing Director of the Aditya Jyot Eye Hospital in Mumbai speaks about his lecture about novel VR surgery for complex diabetic TRD.
Diabetic Eye Care – providing best care in a virtual environment
Tunde Peto, MD, PhD, Professor of Clinical Ophthalmology at Queen’s University Belfast, summarises her presentation about giving the best care in a virtual environment for patients with diabetic retinopathy.
Efficacy of IV aflibercept administered using T&E in patients with ME secondary to CRVO: Post hoc analysis of the CENTERA study
Jean-François Korobelnik, MD, PhD, Professor of Ophthalmology at the University Hospital of Bordeaux (France) speaks about his presentation about the post hoc analysis of the CENTERA study.
Neuroprotective strategy for non arteritic CRVO
Dr. Ogugua Okonkwo from the Eye Foundation Center For The Prevention of Blindness in Lagos (Nigeria) summarises his lecture about neuroprotective strategy for non arteritic CRVO, who won the prestigious Kreissig Lecture at Euretina Virtual 2021.
